*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Sodium (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-4-yl)oxy)acetate</strong> is a pharmaceutical intermediate used in oncology synthesis. It features a complex heterocyclic scaffold with defined stereochemistry.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Key precursor for kinase inhibitors targeting specific cancer mutations.</li>
<li><strong>Research & Development:</strong> Utilized in high-throughput screening assays for drug efficacy validation.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at 2-8°C. Avoid direct skin contact; use appropriate PPE during handling to prevent inhalation of dust particles.</p>